COVID 19 and behavioural science
The recent coronavirus outbreak is a clear concern for everyone. What has been interesting to me is how front and centre behavioural science has been in the government’s response to the ongoing crisis. In listening to the Prime Minister in his address to the UK nation on Monday it was noteworthy in his statements how, when he references the role of science in guiding their approach, he explicitly talked as much about behavioural science as he did about the science behind the disease.
Pharmaceutical Market Research Conference 2020 round-up
Earlier this month Director, Head of NY Office, Liza Pliss and Director, Head of Philadelphia Office, Head of MedTech Division, Sabera Hyderally attended the Pharmaceutical Market Research Conference in Newark, New Jersey.
Catching up with Coronavirus: The race to contain the outbreak is on
As Coronavirus continues to spread across the globe, Rachel Howard explores what pharma is doing to advance research into the virus, considering lessons learned from previous public health emergencies of international concern.
Over the last month, our newsfeeds have increasingly been dominated by updates on the novel coronavirus (COVID-19) outbreak. Believed to have originated in a live animal market in the Chinese city of Wuhan, at the time of publishing COVID-19 has registered over 75,000 confirmed cases and 2000 deaths, with 29 countries and territories affected. nCoV is in the same family as SARS (Severe Acute Respiratory Syndrome), another strain of coronavirus identified in 2003. While nCoV looks likely to have a lower fatality rate, it has spread much more quickly, with the number of reported cases already having rapidly overtaken SARS and continuing to grow by the day. All indications suggest the virus is highly contagious – including, critically, at the stage before an individual displays any symptoms of infection. This outbreak was declared as a public health emergency of international concern (PHEIC) by the World Health Organization (WHO) on 30th January 2020, making it the sixth such emergency since the International Health Regulations came into force in 2005: H1N1 influenza virus (swine flu) in 2009 Wild poliovirus resurgence in 2014 West Africa Ebola virus 2014 Zika virus in 2016 Kivu Ebola virus in 2019 Declaring an outbreak as a PHEIC, in…
Pharmaceutical Market Research Conference 2020
We are delighted to be attending and presenting at the Pharmaceutical Market Research Conference on 5-6 February, in Newark, New Jersey.
Representing Research Partnership will be Director, Head of NY Office, Liza Pliss and Director, Head of Philadelphia Office, Head of MedTech Division, Sabera Hyderally.
Chicago Intellus Regional Event round up 2019
On 11th September, Director, Phil Rosenberg and about 60 other delegates attended the first Intellus regional event hosted in the beautiful Chicago Botanical Gardens.